Understanding Drug Resistance in Breast Cancer Cells
Author Information
Author(s): Stacey L Hembruff, Monique L Laberge, David J Villeneuve, Baoqing Guo, Zachary Veitch, Melanie Cecchetto, Amadeo M Parissenti
Primary Institution: Regional Cancer Program, Sudbury Regional Hospital, Sudbury, ON Canada
Hypothesis
Can the onset and magnitude of drug resistance in breast cancer cells be correlated with the expression of drug transporters?
Conclusion
Drug resistance in breast tumor cells occurs only at specific drug concentrations, and is not solely due to changes in drug accumulation or transporter activity.
Supporting Evidence
- Resistance to chemotherapy drugs was only observed at specific threshold doses.
- Changes in drug accumulation were correlated with the onset of drug resistance.
- The expression of drug transporters varied depending on the drug used for selection.
Takeaway
Breast cancer cells can become resistant to drugs only when exposed to enough of the drug, and just because they take in less drug doesn't mean they are more resistant.
Methodology
MCF-7 breast cancer cells were selected for resistance to various chemotherapy drugs by gradually increasing drug concentrations and assessing drug sensitivity and transporter expression.
Limitations
The study primarily focuses on in vitro models, which may not fully replicate in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website